Anemia – Health

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Iron-Deficiency Anemia During Pregnancy Affects Child’s Brain Development

We often talk about the importance of planning for pregnancy. In these discussions, we emphasize the importance of supplementation with folic acid as a means of decreasing risk for birth defects and improving neurodevelopmental outcomes in children. A recent study indicates that adequate levels of iron may also play an important role in fetal brain… Read More »